The Australian life sciences sector is having a great 2024, we take a deep dive into some of the strongest performers.

Recce Pharmaceuticals and Dimerix are two Australian biotech and pharma companies positioned to deliver solid returns to investors.

In 2020 The World Health Organization (WHO) released its first report on the global epidemiology and burden of sepsis. The report...

Nimy Resources Ltd Positive news from diamond drill holes Nimy Resources announced some positive news from its fourth diamond drill hole...

It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...

Antisense Therapeutics Limited (ASX: ANP; FSE: AWY) Antisense is an Australian publicly listed biotechnology company (with German...

German and European investors have been buying global equities (with a dual listing on Frankfurt and German stock exchanges) in record...

European investors have shown strong interest in Antisense Therapeutics Limited (ASX: ANP: FWB: AWY) since the company was dual listed in...

Platform technology Using mRNA as a medicine is a radically different approach than treating disease with other drug classes. mRNA is the...

Recce Pharmaceuticals Ltd (ASX: RCE) and (FSE: R9Q) is pioneering a new class of synthetic anti-infectives to address the urgent global...

Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...

As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...

Immutep (ASX: IMM) and (FRA: YP1B) are the global leaders in understanding and development of therapeutics that modulate Lymphocyte...

Australian based innovative biotech company, Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) received a strong brokers...

RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...

The recent news that BioNTech and Pfizer’s Covid-19 vaccine was more than 90 per cent effective in clinical trials has increased...

Australia has ranked in the top five globally for biotechnology three years running, outperforming nations such as the United Kingdom and...

An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...